Russell Investments Group’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.93M | Buy |
23,447
+2,362
| +11% | +$765K | 0.01% | 1151 |
|
|
2025
Q4 | $6.41M | Buy |
21,085
+2,759
| +15% | +$903K | 0.01% | 1163 |
|
|
2025
Q3 | $6.24M | Buy |
18,326
+4,723
| +35% | +$1.43M | 0.01% | 1178 |
|
|
2025
Q2 | $3.29M | Buy |
13,603
+4,387
| +48% | +$1.08M | ﹤0.01% | 1456 |
|
|
2025
Q1 | $2.51M | Buy |
9,216
+9,202
| +65,729% | +$2.15M | ﹤0.01% | 1559 |
|
|
2024
Q4 | $2.59K | Sell |
14
-13,842
| -100% | -$2.83M | ﹤0.01% | 3399 |
|
|
2024
Q3 | $3.11M | Buy |
13,856
+13,835
| +65,881% | +$2.49M | ﹤0.01% | 1452 |
|
|
2024
Q2 | $3K | Buy |
+21
| New | +$3.24K | ﹤0.01% | 3305 |
|
|
2024
Q1 | – | Sell |
-6,650
| Closed | -$1.2M | – | 3376 |
|
|
2023
Q4 | $1.2M | Sell |
6,650
-418
| -6% | -$75.6K | ﹤0.01% | 1876 |
|
|
2023
Q3 | $1.27M | Sell |
7,068
-9,502
| -57% | -$1.88M | ﹤0.01% | 1802 |
|
|
2023
Q2 | $2.95M | Sell |
16,570
-7,974
| -32% | -$1.84M | 0.01% | 1337 |
|
|
2023
Q1 | $5.3M | Buy |
24,544
+18,429
| +301% | +$4.42M | 0.01% | 1081 |
|
|
2022
Q4 | $1.36M | Buy |
6,115
+3,696
| +153% | +$678K | ﹤0.01% | 1811 |
|
|
2022
Q3 | $326K | Sell |
2,419
-1,100
| -31% | -$189K | ﹤0.01% | 2397 |
|
|
2022
Q2 | $569K | Sell |
3,519
-2,670
| -43% | -$417K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $1.17M | Sell |
6,189
-516
| -8% | -$110K | ﹤0.01% | 1885 |
|
|
2021
Q4 | $1.82M | Sell |
6,705
-633
| -9% | -$214K | ﹤0.01% | 1847 |
|
|
2021
Q3 | $2.66M | Buy |
7,338
+4,622
| +170% | +$1.51M | ﹤0.01% | 1657 |
|
|
2021
Q2 | $932K | Sell |
2,716
-1,282
| -32% | -$425K | ﹤0.01% | 2345 |
|
|
2021
Q1 | $1.39M | Buy |
3,998
+76
| +2% | +$25.2K | ﹤0.01% | 2091 |
|
|
2020
Q4 | $1M | Buy |
3,922
+2,824
| +257% | +$777K | ﹤0.01% | 2117 |
|
|
2020
Q3 | $311K | Sell |
1,098
-56,528
| -98% | -$13.3M | ﹤0.01% | 2600 |
|
|
2020
Q2 | $10.9M | Sell |
57,626
-65,526
| -53% | -$10.7M | 0.02% | 697 |
|
|
2020
Q1 | $15.2M | Sell |
123,152
-42,194
| -26% | -$6.6M | 0.04% | 489 |
|
|
2019
Q4 | $27.4M | Sell |
165,346
-9,850
| -6% | -$1.64M | 0.05% | 419 |
|
|
2019
Q3 | $21.5M | Sell |
175,196
-107,561
| -38% | -$14.3M | 0.04% | 504 |
|
|
2019
Q2 | $35.1M | Sell |
282,757
-115,787
| -29% | -$14.7M | 0.07% | 367 |
|
|
2019
Q1 | $52.5M | Buy |
398,544
+113,796
| +40% | +$15.4M | 0.1% | 243 |
|
|
2018
Q4 | $39.9M | Buy |
284,748
+178,984
| +169% | +$23.7M | 0.09% | 255 |
|
|
2018
Q3 | $18.2M | Buy |
105,764
+13,077
| +14% | +$2.2M | 0.03% | 623 |
|
|
2018
Q2 | $14.2M | Sell |
92,687
-9,018
| -9% | -$1.61M | 0.03% | 709 |
|
|
2018
Q1 | $17.1M | Buy |
101,705
+62,597
| +160% | +$8.48M | 0.03% | 697 |
|
|
2017
Q4 | $3.83M | Buy |
+39,108
| New | +$3.58M | 0.01% | 1482 |
|
Other funds holding ONC
BBA
HA
Russell Investments Group's ONC Position: Q1 2026 in Review
Russell Investments Group increased its BeOne Medicines Ltd (ONC) stake by 11% in Q1 2026, buying an estimated $765K and bringing the position to 23,447 shares worth $6.93M. The position accounts for 0.01% of the portfolio, ranked #1151.
Russell Investments Group first reported a position in ONC in Q4 2017 and has held it in 33 quarters since. The position peaked at $52.5M in Q1 2019. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Russell Investments Group held 23,447 shares of BeOne Medicines Ltd worth $6.93M as of Q1 2026.
- Russell Investments Group bought 2,362 BeOne Medicines Ltd shares in Q1 2026, an estimated $765K.
- BeOne Medicines Ltd made up 0.01% of Russell Investments Group's portfolio in Q1 2026, its #1151 holding.
- Russell Investments Group first reported a position in BeOne Medicines Ltd in Q4 2017 and has held it in 33 quarters since.
- Russell Investments Group's BeOne Medicines Ltd position peaked at $52.5M in Q1 2019.
- 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.